CANTA, ANNALISA ROSANNA
 Distribuzione geografica
Continente #
NA - Nord America 10.897
EU - Europa 6.173
AS - Asia 3.184
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 23
SA - Sud America 21
AF - Africa 16
Totale 20.352
Nazione #
US - Stati Uniti d'America 10.701
DE - Germania 1.251
SG - Singapore 1.189
IT - Italia 1.146
CN - Cina 1.073
SE - Svezia 962
IE - Irlanda 830
RU - Federazione Russa 558
UA - Ucraina 503
GB - Regno Unito 305
HK - Hong Kong 276
CA - Canada 188
FI - Finlandia 167
VN - Vietnam 150
AT - Austria 118
ID - Indonesia 116
IN - India 112
FR - Francia 105
KR - Corea 78
JP - Giappone 72
DK - Danimarca 70
BE - Belgio 39
TR - Turchia 38
NL - Olanda 33
AU - Australia 22
IR - Iran 21
PL - Polonia 21
EU - Europa 20
NZ - Nuova Zelanda 16
BR - Brasile 15
TW - Taiwan 13
RO - Romania 11
EG - Egitto 10
ES - Italia 8
HR - Croazia 8
MY - Malesia 8
PK - Pakistan 8
BG - Bulgaria 7
IL - Israele 7
PT - Portogallo 7
CH - Svizzera 6
CZ - Repubblica Ceca 5
MX - Messico 5
AE - Emirati Arabi Uniti 4
SA - Arabia Saudita 4
CO - Colombia 3
IQ - Iraq 3
LB - Libano 3
LT - Lituania 3
PH - Filippine 3
RS - Serbia 3
ZA - Sudafrica 3
A1 - Anonimo 2
GT - Guatemala 2
HU - Ungheria 2
MD - Moldavia 2
NO - Norvegia 2
SC - Seychelles 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CL - Cile 1
CR - Costa Rica 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
PE - Perù 1
TH - Thailandia 1
VE - Venezuela 1
Totale 20.352
Città #
Ann Arbor 2.459
Singapore 995
Woodbridge 853
Dublin 812
Chandler 808
Frankfurt am Main 702
Houston 612
Wilmington 545
Jacksonville 535
Fairfield 480
Milan 457
Dearborn 436
Ashburn 434
New York 348
Santa Clara 346
Princeton 282
Hong Kong 256
Seattle 211
Boardman 189
Nanjing 185
Shanghai 150
Cambridge 141
Vienna 118
Jakarta 114
Beijing 98
Guangzhou 86
Lachine 84
Lawrence 80
Dong Ket 77
Altamura 74
Helsinki 67
Shenyang 60
Nanchang 59
Andover 49
Grafing 45
Chicago 43
Toronto 43
Falls Church 42
Fremont 40
Pune 40
San Diego 39
Carate Brianza 35
Nürnberg 35
Jinan 34
Los Angeles 34
Jiaxing 32
Brussels 31
Kunming 29
Tianjin 29
Ottawa 28
Melzo 26
Norwalk 26
Changsha 25
Rome 25
Daejeon 24
Zhengzhou 24
Hangzhou 23
Mountain View 22
Sacramento 22
Shangdi 22
London 21
Tokyo 21
Bergamo 18
Hebei 18
Codroipo 17
Dallas 16
Hefei 15
Ningbo 15
Leawood 14
Lissone 14
Mainz 14
Edmonton 13
Huizen 13
Washington 13
Kraków 12
Seoul 12
Shinjuku 12
Taizhou 12
Auburn Hills 11
Bologna 11
Lappeenranta 11
San Mateo 11
Sesto San Giovanni 11
Florence 10
Kiev 10
Phoenix 10
Romola 10
Canazei 9
Wuhan 9
Cagliari 8
Fuzhou 8
Paris 8
Boston 7
Chongqing 7
Como 7
Kuala Lumpur 7
Trieste 7
Ahmedabad 6
Ardabil 6
Changchun 6
Totale 14.480
Nome #
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 383
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 305
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 300
Age-related changes in the function and structure of the peripheral sensory pathway in mice 297
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 239
Enhanced brain targeting of engineered solid lipid nanoparticles 237
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 236
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 219
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 218
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 211
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 209
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 208
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 205
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain 203
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 200
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 199
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 198
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 197
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 192
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 186
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 185
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 185
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 185
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 183
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 182
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 181
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 180
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 178
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 176
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 175
Enhanced brain targeting of engineered solid lipid nanoparticles 175
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 174
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 173
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 172
OCT2 transporter involvement in development of cisplatin toxicity 172
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 171
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 169
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 169
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 168
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 164
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 163
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 163
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 162
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 162
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 162
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 162
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 159
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 159
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 158
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 158
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 158
The neuroprotective effect of erythropoietin (EPO) and of its non-erythropoietic carbamylated derivative (CEPO) in cisplatin-induced peripheral neurotoxicity 157
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 157
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 154
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 154
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 153
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 153
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation 152
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 152
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 149
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 147
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 144
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 140
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 139
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 139
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 137
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 136
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 136
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 135
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 131
Multimodal experimental approach to the study of human neurological diseases 130
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 130
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 129
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 128
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 128
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 128
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 128
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 128
Genetic factors influencing the development of vincristine-induced neurotoxicity 127
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 127
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 126
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 126
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 125
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 125
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 125
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 123
Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine 123
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 121
Effect of proteasome inhibition on the central and peripheral nervous system 121
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 120
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 120
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 119
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 117
Organic cation transporters and cisplatin-induced peripheral neurotoxicity in dorsal root ganglia neurons 115
Glutamate Carboxypeptidase II inhibition in several rat models of chemotherapy-induced peripheral neurotoxicity 115
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 113
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat 111
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 110
Glutamate Carboxypeptidase II (GCPII, NAALADASE) inhibition protects against Cisplatin-induced peripheral neurotoxicity in a rat model. 110
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 110
Totale 16.348
Categoria #
all - tutte 75.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.128


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.821 0 0 0 0 0 389 480 175 266 254 212 45
2020/20212.832 140 129 318 276 235 254 314 247 241 217 178 283
2021/20221.893 132 194 143 200 168 212 91 89 91 133 144 296
2022/20233.477 363 887 321 358 276 535 61 176 277 56 103 64
2023/20242.911 97 106 106 134 345 709 519 176 136 65 65 453
2024/20253.053 385 826 683 331 581 247 0 0 0 0 0 0
Totale 21.457